Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of a drug called bevacizumab (Avastin) on
the rates of recurrent retinal detachment and scar tissue formation.